跳至主要内容
临床试验/NCT05689268
NCT05689268已完成不适用

EUS-portal Pressure Gradient (EUS-PPG). Prospective Study Compared With Hepatic Venous Pressure Gradient (HVPG)

Hospital General Universitario de Alicante2 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
33
试验地点
2
主要终点
Intra-class correlation coefficient between portal pressure gradient measurement by EUS and hepatic venous pressure gradient measurement measured by interventional radiology.

研究概览

简要总结

The objective of this study is to evaluate the correlation of the calculated portal pressure gradient (PPG) obtained by direct portal and hepatic pressure measurements with a conventional 22 G needle guided by EUS and indirect portal vein pressure measurements using the interventional radiology based hepatic venous pressure gradient (HVPG) procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age above 18 years
  • Undergoing evaluation for chronic liver disease or portal hypertension
  • Signed informed consent

排除标准

  • Uncorrectable coagulopathy (INR above 1.5)
  • Uncorrectable thrombocytopenia (Platelets under 50,000)
  • Anticoagulation or antiplatelet therapy that cannot be discontinued
  • Biliary obstruction
  • Grade II ascites or more
  • Intrahepatic portal vein thrombosis
  • Pregnancy

结局指标

主要结局

Intra-class correlation coefficient between portal pressure gradient measurement by EUS and hepatic venous pressure gradient measurement measured by interventional radiology.

时间窗: 1 day

Portal pressure gradient measurement will be performed by direct echoendoscopy-guided puncture with a 22 G needle of the portal vein and the suprahepatic vein. On the same day or on successive days, hepatic venous pressure gradient determination will be performed by interventional radiology. For this purpose, the free hepatic venous pressure and the wedged pressure will be measured using a balloon catheter and jugular approach, following the usual procedure.

次要结局

  • Technical success of both procedures measured as the number of procedures successfully performed divided by the total number of patients.(1 day)
  • Adverse effects at 30 days after each procedure by clinical follow-up of patients at 24 hours, 7 days, and 30 days using the American Society of Gastrointestinal Endoscopy Severity grading system, from mild to fatal.(30 days)

研究者

发起方
Hospital General Universitario de Alicante
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jose Ramon Aparicio Tormo

Head of Endoscopy Unit

Hospital General Universitario de Alicante

研究点 (2)

Loading locations...

相似试验

EUS-PPG vs HVPG in Portal Hypertension | 临床试验